Elanco Raises Full-Year Guidance After Q2 2026 Revenue Beats Estimates
Elanco reports 8% organic constant currency growth in Q2 2026, exceeding guidance and prompting an upward revision for annual targets. Elanco Animal Health (ELAN) posted 8% organic constant currency revenue growth in Q2 2026, surpassing the high end of its guidance range.